cobalt has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, KS; Gopalakrishnan, AV; Iyer, M; Raj, N; Suriyanarayanan, A; Vellingiri, B; Venkatesan, D | 1 |
| Chai, ZF; Chen, J; Hu, Y; Lan, AP | 1 |
| Aguilar, MV; Arrieta, FJ; Ayuso-Peralta, L; Cabrera-Valdivia, F; García-Albea, E; Jiménez-Jiménez, FJ; Jorge-Santamaría, A; Molina, JA; Rabasa, M; Vázquez, A | 1 |
| Davis, JM; Dekirmenjian, H; Manian, AA; Rajan, KS | 1 |
2 review(s) available for cobalt and Parkinson Disease
| Article | Year |
|---|---|
Influence of heavy metals in Parkinson's disease: an overview.
Topics: alpha-Synuclein; Chromium; Cobalt; Humans; Mercury; Metals, Heavy; Nickel; Parkinson Disease; Thallium | 2022 |
The neurotoxicity of iron, copper and cobalt in Parkinson's disease through ROS-mediated mechanisms.
Topics: Cobalt; Copper; DNA Damage; Humans; Iron; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Reactive Oxygen Species | 2016 |
2 other study(ies) available for cobalt and Parkinson Disease
| Article | Year |
|---|---|
Serum and urinary manganese levels in patients with Parkinson's disease.
Topics: Activities of Daily Living; Aged; Brain; Chromium; Cobalt; Female; Humans; Lipid Peroxidation; Male; Manganese; Metabolic Clearance Rate; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors | 1995 |
Metal chelates of L-DOPA for improved replenishment of dopaminergic pools.
Topics: Animals; Chelating Agents; Chemical Phenomena; Chemistry; Cobalt; Copper; Levodopa; Magnesium; Metals; Parkinson Disease; Rats; Time Factors; Zinc | 1976 |